In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-16 of 16 for your search:
Drug:  peginterferon alfa-2b
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Active
Age: 60 and over
Sponsor: Other
Protocol IDs: MCL2004-1, NCT00209209

2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: daliah2011, NCT01387763

3.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: EORTC-18081, 2009-010273-20, NCT01502696

4.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CML V, 2010-024262-22, NCT01657604

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Approved-not yet active
Age: Over 18
Sponsor: Other
Protocol IDs: VEMUPLINT, NCT01959633

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 3475-029, 2013-004072-36, NCT02089685

7.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 months to 21 years
Sponsor: NCI, Other
Protocol IDs: UPCI 06-116, NCT00396019

8.

Phase: Phase II
Type: Treatment
Status: Active
Age: 6 months to 21 years
Sponsor: NCI
Protocol IDs: 080130, 08-C-0130, NCI-08-C-0130, NCI-P06096, NCT00678951

9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 2 to 30
Sponsor: Other
Protocol IDs: 2008-260, NCT00846430

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: NordCML007, 2011-005989-38, NCT01725204

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NordDutchCML009, 2012-004321-25, NTR 3732, NCT01866553

12.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 65
Sponsor: Other
Protocol IDs: DASA-PegIFN, NCT01872442

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 months to 25 years
Sponsor: NCI, Other
Protocol IDs: PBTC-039, NCI-2013-01639, U01CA081457, NCT01964300

14.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 4031-400, NCT02155322

15.

Phase: Phase I
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: 13-105, NCT02112032

16.

Phase: No phase specified
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Merck MISP 50422, NCT01986712
New Search